- Home
- XNCR vs NMFC Comparison
XNCR vs NMFC Comparison
Compare XNCR & NMFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | NMFC |
|---|---|---|
| Founded | 1997 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 972.8M |
| IPO Year | 2013 | 2011 |
Fundamental Metrics
Financial Performance| Metric | XNCR | NMFC |
|---|---|---|
| Price | $18.36 | $9.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | ★ $23.20 | $10.00 |
| AVG Volume (30 Days) | ★ 758.3K | 503.3K |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 13.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | $150,132,000.00 | ★ $340,877,000.00 |
| Revenue This Year | $22.09 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.61 |
| Revenue Growth | ★ 38.16 | N/A |
| 52 Week Low | $6.92 | $8.84 |
| 52 Week High | $27.24 | $12.05 |
Technical Indicators
Market Signals| Indicator | XNCR | NMFC |
|---|---|---|
| Relative Strength Index (RSI) | 68.18 | 56.97 |
| Support Level | $15.69 | $9.53 |
| Resistance Level | $17.83 | $9.73 |
| Average True Range (ATR) | 1.01 | 0.17 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 91.72 | 84.15 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About NMFC New Mountain Finance Corporation
New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.